Actively hiring
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$250k
2 rounds on record
Latest round
$100k
Venture round · Jan 2024 · 2 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
33 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 15, 2024
Raised a round Venture round $100k · SEC Form D
Nov 17, 2020
Raised a round Venture round $150k · SEC Form D
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2024 | $100k | — | SEC Form D |
| Venture round | Nov 2020 | $150k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Dome Therapeutics, LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Jordan GreenExecutive Officer, DirectorSEC Form D
Alfredo Quinones-HinojosaExecutive OfficerSEC Form D
Kyung-Soo LiewExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

With our opti-ox™ technology, we precisely, consistently, & efficiently reprogram stem cells into any cell type at scale for your research…

Vetbiolix is a veterinary biotech developing first-in-class therapeutics for pets. Targeting Osteoarthritis, Periodontitis & Gut Motility…

Conception combines stem cell biology and engineering to create new possibilities for having children.

Explore stem cells and regenerative medicine. Learn about mCELL™, published research, and resources for patients and physicians.

Imagine a brighter future. Geneus Biotech is committed to reducing intensive animal farming, waste and pollution through a unique patented…

Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.
Overview
Dome Therapeutics is a preclinical biotech developing a nanomedicine that targets the brain cancer stem cells behind glioblastoma recurrence.
People

Jordan Green
Executive Officer, Director

Alfredo Quinones-Hinojosa
Executive Officer

Kyung-Soo Liew
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data





